Human spermatogonial stem cells (SSCs) play critical roles in lifelong maintenance of male fertility and regeneration of spermatogenesis. These cells are expected to provide an important resource for male fertility preservation and restoration. A basic strategy has been proposed that would involve harvesting testis biopsy specimens from a cancer patient prior to cancer therapies, and transplanting them back to the patient at a later time; then, SSCs included in the specimens would regenerate spermatogenesis. To clinically apply this strategy, isolating live human SSCs is important. In this study, we investigated whether CD9, a known rodent SSC marker, is expressed on human male germ cells that can repopulate recipient mouse testes upon transplantation. Testicular tissues were obtained from men with obstructive azoospermia. Using immunohistochemistry, we found that CD9 was expressed in human male germ cells in the basal compartment of the seminiferous epithelium. Following immunomagnetic cell sorting, CD9-positive cells were enriched for germ cells expressing MAGEA4, which is expressed by spermatogonia and some early spermatocytes, compared with unsorted cells. We then transplanted CD9-positive cells into nude mouse testes and detected an approximately 3-to 4-fold enrichment of human germ cells that repopulated mouse testes for at least 4 mo after transplantation, compared with unsorted cells. We also observed that some cell turnover occurred in human germ cell colonies in recipient testes. These results demonstrate that CD9 identifies human male germ cells with capability of long-term survival and cell turnover in the xenogeneic testis environment.
INTRODUCTION
The activity of spermatogonial stem cells (SSCs) is the foundation of spermatogenesis. These cells can self-renew for a lifetime and give rise to progeny that are committed to differentiation, thereby supporting continuous sperm production during steady-state spermatogenesis. Because of this unique potential, SSCs also play a critical role in the regeneration of spermatogenesis following testicular injuries. It has been demonstrated in the mouse that treatment with an alkylating agent, busulfan, induces male infertility. Upon transplantation into testes of these infertile mice, SSCs migrate to the basal compartment of the seminiferous epithelium and colonize recipient testes, leading to regeneration of spermatogenesis and restoration of fertility [1, 2] . This experimental scheme has been proposed to be applicable in clinical settings to safeguard male fertility for patients who undergo cytotoxic cancer therapies [3] . The SSCs can be harvested prior to anticancer therapies, and following in vitro amplification, they can be autologously transplanted back to a patient's testes to restore male fertility. Because mouse male germ cells in fetal testes are known to possess the capacity to colonize and regenerate spermatogenesis upon transplantation into postnatal testes [4] , the SSC transplantation approach can be expected to be beneficial for men of any age.
A caveat to this approach is the potential transmission of tumorigenic cells infiltrating testis tissues. To circumvent this risk, immunological separation of germ cells from cancer cells has been investigated. An animal study showed that leukemic cells can be largely purged from testis cells by immunological cell separation using two cell-surface antigens, a major immunohistocompatibility complex class I (MHC-I) molecule, and CD45 pan-hematopoietic antigen as markers [5] . Transplantation of the resulting cells in the marker-negative fraction prevented cancer transmission while allowing for generation of functional sperm. However, Geens et al. [6] showed that positive selection of germ cells only or negative selection of leukemic cells alone was insufficient to decontaminate testicular cell preparations. Another study concluded that germ cell selection in combination with leukemic cell depletion prevented leukemia transmission in association with transplantation of the sorted cells [7] . With emerging evidence that leukemic stem cells may evolve and change their immunophenotypes [8, 9] , identification of multiple human SSC markers for cell enrichment is critical.
Accumulating evidence suggests that SSC markers are conserved considerably from mice to nonhuman primates [10] ; thus, rodent SSC markers are expected to be applicable to human SSCs. However, a recent study suggests that some differences appear to exist between human SSCs and the SSCs of other species [11] , even though a degree of conservation has been observed across species [10] [11] [12] [13] . Such a finding highlights the importance that the applicability of rodent SSC markers to human SSCs needs to be verified on a molecule-bymolecule and species-by-species basis.
To identify SSC markers in various animal species, transplantation into nude mice has been used as a functional assay [10] [11] [12] [13] . This transplantation assay is an unequivocal functional assay of SSCs when complete spermatogenesis is regenerated, as seen in mouse-to-mouse transplantation [14] . However, human spermatogenesis cannot be completed in this xenogeneic environment [15] , and thus this technique has a weakness in detecting the ability of SSCs to support differentiation. Nonetheless, it allows for identifying human germ cells that can migrate to the basal compartment of mouse seminiferous epithelium, where daughter cells proliferate and survive for a long time [12, 13, 15] . These functions represent the key characteristics of SSCs and are essential when human SSCs are to be used for male fertility restoration through transplantation. Thus, xenotransplantation is a logical functional detection method available for human spermatogonial stem/progenitor cells [10, 13] .
SSEA4 is thus far the only marker identified for human stem/progenitor spermatogonia through the functional transplantation assay [11] . Here, we tested a hypothesis that CD9 is expressed on human male germ cells with colonizing/ repopulating activity. CD9 is a known cell-surface marker of rodent SSCs [16] and belongs to the tetraspanin superfamily. Tetraspanins interact with other proteins, such as integrins, immunoglobulins, proteoglycans, complement-regulatory proteins, and growth factor receptors. CD9 is involved in cell adhesion and contributes to functional regulation of integrins [17] . It can also regulate cell migration and proliferation, as well as egg-sperm fusion [18, 19] . Although various types of differentiated somatic cells express CD9 [17, [20] [21] [22] [23] , some stem cells, such as embryonic stem cells [24] , hematopoietic stem cells [25] , and neural stem cells [26] , also express this molecule. In human testes, CD9 expression was detected in the basal compartment of the seminiferous epithelium using immunohistochemistry [27] , but its expression on human SSCs has not been documented.
In this study, using immunological cell sorting and xenotransplantation, we evaluated the repopulation potential of CD9-positive (CD9 þ ) human male germ cells. Our results indicated that upon transplantation into mouse testes, CD9 þ cells generated more colonies of human germ cells that were maintained for at least 4 mo, compared with unsorted human testis cells. We also obtained results that are suggestive of cell turnover taking place in these colonies. The data thus support that CD9 is expressed not only on mouse SSCs but also on human male germ cells with repopulation potential, and may help the development of clinical approaches to male fertility restoration through transplantation.
MATERIALS AND METHODS

Patients
Human testis tissues were obtained from 18 adult males with obstructive azoospermia, aged on average 44.6 6 1.3 yr (39-50 yr). Tissues were obtained through aspiration using a minimal invasive technique using a 16-to 18-gauge intravenous catheter inserted percutaneously under local anesthesia, as previously described [28] . Among the samples from 18 patients, those from 9 patients were used for immunostaining with or without cell sorting, whereas those from 6 patients were used for cell sorting followed by xenotransplantation. The remaining three samples were used in preliminary transplantation experiments. This study was approved by the institutional ethics review board, and informed consent was obtained from all participants.
Immunohistochemistry
Human testicular biopsies were fixed with Bouin solution for 6 h. Paraffinembedded samples were sectioned at 5-lm thickness. For immunostaining for CD9 or GFRA1, samples were treated with blocking solution (PBS with 5% donkey serum) overnight at 48C and reacted with either polyclonal goat antihuman CD9 (sc 7639; Santa Cruz Biotechnology Inc., Santa Cruz, CA) or polyclonal goat anti-human GFRA1 (sc 6157; Santa Cruz Biotechnology), both at a dilution of 1:50 overnight at 48C. Following repeated washes with PBS, positive cells were visualized with fluorescein isothiocyanate-conjugated donkey anti-goat immunoglobulin G (IgG; Jackson Immunoresearch, West Grove, PA). Images of immunostaining were captured under an epifluorescent microscope. To costain for MAGEA4 expression, sections stained for CD9 or GFRA1 were extensively washed with PBS, then treated with 0.3% H 2 O 2 (Sigma, St. Louis, MO) and incubated in blocking solution (PBS with 5% normal goat serum) overnight at 48C. The following day, sections were incubated with monoclonal mouse anti-human MAGEA4 antibodies (clone 57B, kindly provided by Dr. G. C. Spagnoli) [29] [30] [31] [32] [33] [34] at 1:100 overnight at 48C. Samples were then reacted with peroxidase-conjugated goat anti-mouse IgG (Jackson Immunoresearch) at 1:500 for 1 h at room temperature. Positive cells were visualized using 3,3 0 -diaminobenzidine (DAB substrate kit; SK-4100; Vector Laboratories, Burlingame, CA). Images of MAGEA4 staining were merged with those of CD9 or GFRA1 staining to assess the colocalization of positive signals.
To costain for CD9 and ITGA6 (integrin-a 6 or CD49f) expression, serial sections of 5 lm were used. Samples were treated for CD9 staining as described above. For ITGA6 staining in an adjacent section, samples were treated with blocking solution (PBS with 5% normal donkey serum) overnight at 48C and reacted with polyclonal goat anti-human ITGA6 (sc 6596; Santa Cruz Biotechnology) at a dilution of 1:50 overnight at 48C. After repeated washes with PBS, positive cells were visualized with fluorescein isothiocyanate-conjugated donkey anti-goat IgG (Jackson Immunoresearch). Images of immunostaining were captured under an epifluorescent microscope. Images of ITGA6 staining were merged with those of CD9 staining to assess the colocalization of positive signals.
Two sections from each patient were scored for CD9/MAGEA4 or GFRA1/ MAGEA4 colocalization, with a total of 198 and 173 cross sections scored, respectively. For ITGA6/CD9 colocalization, four sections from two patients for each antigen with 81 cross sections were scored.
Cell Preparation
Single suspensions of human testis cells were prepared by digesting biopsy specimens with a mixture of collagenase I, collagenase IV, hyaluronidase, and DNase I (all from Sigma) at 1 mg/ml each in 5 ml of Hanks balanced salt solution (HBSS; Invitrogen, Carlsbad, CA) at 338C for 15 min with periodic shaking. After the initial digestion, human testis cells and tubules were centrifuged at 500 3 g for 5 min and further digested at 338C for 5 min using 0.5 mg/ml trypsin and 1 mg/ml DNase I in HBSS. The mean biopsy weight was 67.1 6 8.3 mg per patient, whereas the mean cell recovery was 8. 
Immunomagnetic Cell Sorting
Cell sorting was performed using samples from each individual participant; thus, cells were not pooled. A single-cell suspension of donor testis cells was divided into control (unsorted) and experimental groups in each experiment. For the experimental group, immunomagnetic cell sorting was done according to the previously described protocol with some modifications [35] . Briefly, cells were suspended in Dulbecco modified Eagle medium (Invitrogen) with 1% fetal bovine serum at a concentration of 6 3 10 6 cells per milliliter and reacted with mouse anti-human leukocyte antigen (HLA)-ABC antibodies (555551; 5 lg/ml; BD Biosciences Pharmingen, Franklin Lakes, NJ) on ice for 30 min. This antibody recognizes a human form of a monomorphic epitope of MHC-I antigens widely distributed on nucleated cells. Following washing, the cells were incubated with secondary sheep anti-mouse antibodies conjugated with a magnetic bead (catalogue no. 11031; Invitrogen Dynal AS, Oslo, Norway) on ice for 30 min with gentle agitation. The negative fraction was recovered and incubated with polyclonal goat anti-human CD9 antibodies (5 lg per 6 3 10 6 cells per milliliter) on ice for 30 min, followed by biotin-conjugated donkey anti-goat IgG (Jackson Immunoresearch) on ice for 30 min with gentle agitation. To capture the antibody-bound cells, the M280 streptavidin magnetic beads (catalogue no. 112-05D; Invitrogen Dynal) were used at a 20 ll/ml cell suspension on ice for 30 min with gentle agitation. Cells were then applied to a magnetic cell sorter (Invitrogen Dynal) for 3 min, and antibody-bound cells as well as unbound cells were recovered and cryopreserved at a cell concentration of 5 3 10 6 cells per milliliter. Cells were kept at À808C overnight and stored in liquid nitrogen until transplantation as previously described [15] .
In cytospin experiments, a single-cell suspension from a testicular biopsy was subjected to immunomagnetic cell sorting with anti-human CD9 or antihuman GFRA1 (both at 5 lg/ml) without HLA sorting. For GFRA1 sorting, the primary antibody was as described above, followed by biotin-conjugated donkey anti-goat IgG (Jackson Immunoresearch) on ice for 30 min with gentle agitation. Antibody-bound cells were recognized by magnetic beads, M280 streptavidin, as above. Cells were then applied to a magnetic cell sorter (Invitrogen Dynal) for 3 min. Sorted and unsorted cells were centrifuged at 200 3 g for 15 min on glass slides at a cell concentration of 5 3 10 4 cells per ZOHNI ET AL.
milliliter in 1 ml per specimen chamber. Cells were air-dried and stained for MAGEA4 as in immunohistochemistry.
Transplantation
Ncr nude mice (nu/nu; Taconic, Germantown, NY) served as recipients for human testis cell transplantation. To destroy endogenous spermatogenesis, the recipient mice were treated at 8 wk of age with busulfan (40 mg/kg; Sigma) at least 6 wk before donor cell transplantation. Frozen human testis cells were thawed and resuspended in Dulbecco modified Eagle medium with 0.1 mg/ml DNase and 0.04% trypan blue. Cell viability after thawing was 53.3% 6 1.9% across the cell fractions transplanted (HLA
þ , 53.6%; and unsorted, 52.9%). Because no significant differences were detected among all of the cell fractions, we transplanted all cells (i.e., viable and nonviable cells) into recipient mouse testes. The concentration of donor human cell suspension was 25 3 10 6 cells per milliliter across the groups. Approximately 7 ll of donor cell suspension was introduced into the seminiferous tubules through the rete testis of a recipient mouse [2] . For HLA
þ , and unsorted fractions, 15, 7, 7, and 11 testes were injected and analyzed, respectively. All animal handling and care were performed in accordance with the guidelines established by the Canadian Council on Animal Care.
Analysis of Recipient Testes
Whole-mount immunohistochemistry using anti-human mouse monoclonal MAGEA4 antibody (clone 57B, a kind gift from Dr. G.C. Spagnoli) was performed 2 and 4 mo after transplantation; staining results were analyzed throughout an entire testis. Recipient mouse testes were treated with a mixture of collagenase IV and DNase I (Sigma) at 1 mg/ml each in 5 ml of HBSS (Invitrogen) to disperse the seminiferous tubules and were subsequently fixed in 4% paraformaldehyde at 48C for 2 h. Following extensive washing, testis tubules were treated with 0.3% H 2 O 2 and incubated in blocking solution (PBS with 5% normal goat serum) at 48C overnight. The samples were then processed with the MAGEA4 antibody at 1:100 in PBS with 5% bovine serum albumin at 48C overnight and reacted with peroxidase-conjugated goat antimouse IgG at 1:250 at 48C overnight. MAGEA4
þ human germ cells were visualized using DAB as described above. Stained tubules were fixed in 10% neutral-buffered formalin and kept in PBS at 48C.
Statistical Analyses
Statistical analyses were done using t-tests or, for multiple comparisons, ANOVA followed by Tukey post hoc test. Significance was determined when P , 0.05. All data are expressed as the mean 6 SEM.
RESULTS
Testicular biopsies were derived from adult patients with obstructive azoospermia. Using immunohistochemistry in paraffin sections of human testes, we initially tested antibodies against various antigens known to be expressed by mouse SSCs for their reactivity to human spermatogonia. Among them, anti-CD9 and anti-GFRA1 antibodies gave clear positive signals (Fig. 1, A-H) . The cells stained with either antibody were localized in the basal compartment of human seminiferous epithelium, a typical staining pattern of spermatogonia. We then double-stained CD9 þ or GFRA1 þ cells with MAGEA4 antibodies. MAGEA4 is an oncofetal protein expressed in a variety of malignant neoplasms and, among normal cells, only 
CD9 IS A HUMAN SPERMATOGONIAL PROGENITOR MARKER
in spermatogonia and, to a lesser extent, early spermatocytes [29] [30] [31] [32] [33] [34] . Indeed, we observed positive MAGEA4 signals on germ cells in the basal compartment (Fig. 1, C, G, and H) . Expression of MAGEA4 was clearly observed in CD9 þ or GFRA1 þ cells on the basal membrane, confirming that these two antigens are expressed in human spermatogonia, and possibly early spermatocytes. CD9
þ MAGEA4 þ cells accounted for nearly all (97%) of CD9 single-positive cells while representing 84% of MAGEA4 single-positive cells (Table 1) . Likewise, GFRA1
þ MAGEA4 þ cells were 98% of GFRA1 þ cells and 77% of MAGEA4 þ cells. ITGA6 was previously shown to be expressed by human spermatogonia [11, 36] and nonhuman primate spermatogonial stem/progenitor cells [37] . Thus, we examined whether this molecule is expressed by CD9 þ cells. CD9 þ ITGA6 þ cells accounted for 88% of CD9 single-positive cells while representing 90% of ITGA6 single-positive cells (Fig. 1, I -L, and Table 1 ). Thus, CD9 and GFRA1 are expressed by human spermatogonia, consistent with the results of previous studies [38, 39] .
Based on these results, we next examined whether CD9 and GFRA1 can be used to enrich human testis cells for MAGEA4 þ germ cells using immunomagnetic cell sorting. The sorting efficiency was analyzed by MAGEA4 staining following cytospin of selected cells, in comparison with unsorted cells. The results showed that the CD9 þ and GFRA1 þ cell fractions contained 4-and 4.5-fold more MAGEA4 þ cells, respectively (Fig. 2) . Although both cell-surface antigens allowed a similar enrichment degree of MAGEA4 þ human germ cells, a marked difference was noted in the efficiency of cell recovery. Although ;12% of total cells were recovered in the CD9 þ cell population, only ;3% were collected in the GFRA1 þ cell population ( Table 1 ). The low cell recovery using GFRA1 antibodies was anticipated to cause practical problems for further cell manipulation, particularly when a cell source was limited to testicular biopsies. Therefore, we focused on CD9 as a potential marker for human SSCs in further experiments.
We next asked whether CD9 þ human germ cells possess a capacity to colonize and repopulate nude mouse testes upon transplantation. A single-cell suspension of human testis cells was first sorted immunomagnetically using an antibody against HLA, an MHC-I molecule. MHC-I has been known to be not expressed in human spermatogonia at the protein level [39] [40] [41] [42] . Thus, negative selection for HLA should be beneficial for SSC enrichment, particularly when SSCs are to be used for male fertility restoration in cancer patients. HLA -cells were further sorted into the CD9 þ and CD9 -cell populations. We recovered 66% of total human testis cells in the HLA þ fraction, ;10% in the HLA -CD9 þ fraction, and ;20% in the HLA -CD9 -fraction (Table 2) .
These three cell fractions as well as unsorted cells were transplanted into recipient testes of nude mice. Two or four months following transplantation, human germ cells that colonized and repopulated the xenogeneic testis environment were detected by whole-mount MAGEA4 staining of recipient testes (Fig. 3, A-D , and Supplemental Fig. S1 ; available online at www.biolreprod.org). We confirmed that the MAGEA4 antibody did not cross-react with testis cells of intact mice, denoting that the antibody specifically identifies human germ cells in recipient mouse testes (Fig. 3, E and F) . To assess the enrichment degree of human male germ cells with repopulating potential, we counted the number of cell groups, or colonies, and compared colony numbers across the cell fractions. We defined a colony as a group of four or more cells separated by less than one cell diameter.
Two months after transplantation, the number of colonies in the HLA -CD9 þ cell population was approximately 4-fold ZOHNI ET AL.
greater compared with unsorted cells and 11.7-fold greater compared with HLA -CD9 -cells (Fig. 4) . In the 4-mo experiments, reflecting long-term repopulation, the colony number declined in all groups in comparison with 2-mo experiments. Nonetheless, the HLA -CD9 þ population generated 3.3-fold greater numbers of colonies compared with the unsorted population and 37-fold greater numbers compared with HLA -CD9 -cells (Fig. 4) . The significantly increased colony numbers in HLA -CD9 þ cells relative to unsorted cells at both posttransplantation times indicate that CD9 is expressed on human male germ cells that have the potential for long-term repopulation in the xenogeneic testis environment, and that CD9-based cell sorting leads to enrichment of these cells.
Finally, we compared the distribution of colony sizes (i.e., colonies containing different numbers of cells) between 2 and 4 mo in the HLA -
CD9
þ and unsorted cell fractions. As shown in Figure 5 , the number of colonies containing four cells significantly declined from 2 to 4 mo in both cell fractions, whereas that of colonies carrying five or more cells stayed constant or increased during the same time period. These results suggest that similar to mouse SSC transplantation [43] , human germ cells in colonies did not remain dormant after transplantation and that sustainable turnover of these cells (e.g., proliferation/death) occurred from 2 to 4 mo after transplantation.
DISCUSSION
In this study, we have found that human CD9 þ male germ cells possess the ability to migrate through and colonize the recipient seminiferous epithelium for at least 4 mo upon transplantation. Hence, our results show for the first time that
To detect human germ cells after transplantation, we used MAGEA4 as a human germ cell marker, which is expressed by human spermatogonia and, to a lesser extent, early spermatocytes. We confirmed that its antibody did not cross-react with mouse cells (Fig. 3, E and F) . These characteristics of the marker are important because non-germ cells are known to colonize testes after transplantation [10, 44, 45] . In xenotransplantation experiments, it is insufficient to visualize donor cells in recipient testes by simply using a species-specific marker alone, such as human-specific microsatellites, and therefore additional parameters are required to confirm the cell type [12, 13, 45] . The use of the MAGEA4 antibody in this study allowed for species-specific and cell type-specific identification of colonizing donor cells as human germ cells. Because the consequence of germ cell transplantation is measured only by detection of differentiating germ cells, whole-mount detection for MAGEA4
þ cells allowed us to generate faithful readouts of human germ cell transplantation.
The markers for nonhuman primate SSCs have been analyzed with xenotransplantation [10] . Using this approach combined with fluorescence-activated cell sorting (FACS), Hermann et al. [13, 45] have shown that rhesus monkey spermatogonia expressing THY1 (CD90) exhibit enhanced activity to colonize mouse testes, suggesting that THY1 is conserved with rodent SSCs. Furthermore, THY1 þ cells were PLZF þ , GFRA1 þ , NGN3 þ/-, and KIT -(CD117), which are also characteristics of mouse SSCs [13, 45] . Maki et al. [37] used FACS and xenotransplantation and showed that putative rhesus monkey SSCs express ITGA6 and THY1. The expression of GFRA1, SSEA-4, PLZF, and GPR-125 was detected in these cells, whereas Nanog expression was low and Kit expression was undetectable. These findings have collectively led to the notion that some SSC properties are conserved in a wide range of mammalian species [10] .
For human SSCs, several studies have reported GFRA1, ITGA6, GFR-125, and THY1 as cell-surface markers [34, 36, 39, 46] . However, identification of target molecules in these studies relied on morphological/immunophenotypic characteristics or on the ability of human cells to proliferate in a short- CD9 IS A HUMAN SPERMATOGONIAL PROGENITOR MARKER term culture; thus, the cells were not identified on the basis of stem cell functional definition. Recently, Izadyar et al. [11] have shown that human spermatogonia expressing SSEA-4, which also express ITGA6, have a higher repopulation potential after xenotransplantation than nonexpressing cells, indicating that SSEA-4 is a putative human SSC marker. Interestingly, this study has reported on THY1 expression in cells located in the adluminal compartment of human seminiferous epithelium. Furthermore, ITGB1 was not detected in colonizing human spermatogonia. Because these two antigens are mouse SSC markers, the results highlight apparent differences between human and mouse SSCs. Interestingly, we observed that the number of colonies carrying four cells declined remarkably from 2 to 4 mo after transplantation, but that of colonies with five or more cells was stable or even showed a trend to increase (Fig. 5 ). These observations suggest that donor human germ cells did not merely survive after transplantation, but some of them were replenished and/or proliferated, suggesting the presence of long-term self-renewing cells that sustain colonies of human germ cells, although we cannot rule out the possibility that these colonies enlarged simply because committed cells in selected colonies proliferated.
We employed in this study immunomagnetic cell sorting for putative human SSC enrichment, rather than FACS. Although FACS allows for more strict and multiparameter cell sorting, immunomagnetic cell sorting has practical advantages, which could be beneficial for future clinical applications. First, magnetic cell sorting does not require as many cells as FACS does. Because the source of human germ cells in our study was biopsy specimens, the quantity of available cells was limited. This technical issue should also be an important consideration in clinically applying human SSCs, where harvesting a large number of testis cells is not expected to be a common practice. Second, immunomagnetic cell sorting is rapid and simple, and does not require extensive experience for its adequate performance. Thus, this cell-sorting technique can be readily performed in clinical settings.
In this study, we pretreated human testis cells for negative cell sorting using MHC-I prior to CD9-based selection. Because MHC-I is expressed in all nucleated cells but not in spermatogonia, it is expected to be an important antigen to remove somatic cells, including tumorigenic cells contaminating testis cells. In addition, testis cells are highly heterogeneous, which can reduce the effectiveness of immunological cell sorting [47] . Therefore, the negative cell sorting using MHC-I as a marker should have an additional advantage for human SSC enrichment.
On this basis, we included the MHC-I-negative selection in the current study. Our results (Fig. 4) , however, indicated that colony numbers of human germ cells observed in the HLA þ fraction were not significantly different from those in the unsorted fraction, despite a trend of slight decline. We speculate that this was caused by an inherent weakness in immunomagnetic cell sorting for precise separation and a large coefficient of variation of the in vivo transplantation assay. Nonetheless, a significant enrichment of repopulating human germ cells was detected in the HLA -CD9 þ cells compared with HLA þ cells (Fig. 4) . Thus, although our current data did not 
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clearly demonstrate the effectiveness of HLA-negative selection alone, they did show that CD9 is an effective marker to enrich human testis cells for repopulating germ cells.
Our study adds CD9 to the list of markers for human male germ cells with repopulation potential. Identification of multiple human SSC markers and their degree of SSC enrichment efficiency will be important for biological characterization of these cells and should also provide versatility in the choice of antigens for cell sorting. This is particularly important in the clinical context of harvesting SSCs for fertility preservation for cancer patients, because different types of tumors express varied markers. This notion is further emphasized by the recent studies reporting that leukemia stem cells evolve and change their immunophenotypic characteristics over time [8, 9] . Thus, further identification of additional human SSC markers will be beneficial to distinguish SSCs from cancer stem cells. Future studies should also be directed toward determining which marker allows for the most effective human SSC enrichment. These are important issues to be addressed to realize human SSC-based male fertility restoration in clinical settings.
